Page last updated: 2024-12-05
dibenzo(a,c)phenazine
Description
Dibenzo(a,c)phenazine is a heterocyclic aromatic compound with a complex structure containing two fused benzene rings and a central phenazine ring. It has been studied for its potential applications in various fields, including:
* **Synthesis:** Dibenzo(a,c)phenazine can be synthesized through various methods, such as the condensation reaction of o-phenylenediamine with 1,2-diketones.
* **Effects:** The compound exhibits fluorescent properties and has been investigated for its potential as a dye, sensor, and in organic electronics.
* **Importance:** Dibenzo(a,c)phenazine derivatives have shown potential as bioactive compounds with anticancer, antimicrobial, and anti-inflammatory activities.
* **Research:** Ongoing research focuses on exploring its structural modifications to enhance its properties and explore its potential as a building block for novel materials and pharmaceuticals.'
dibenzo(a,c)phenazine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 9166 |
| SCHEMBL ID | 732274 |
| MeSH ID | M0509082 |
Synonyms (37)
| Synonym |
|---|
| dibenzo[a,c]phenazine |
| phenanthro[9,10-b]quinoxaline |
| 1,4-dibenzophenazine |
| phenanthro-9',3-quinoxaline |
| 9,c]anthracene |
| 215-64-5 |
| nsc6945 |
| nsc-6945 |
| wln: t j6 d6 c666 bn qnj |
| 1,3,4-dibenzphenazine |
| 9,14-diazadibenz[a,c]anthracene |
| phenanthro(9,10-b)quinoxaline |
| 9,14-diazadibenz(a,c)anthracene |
| phenanthrazine (van) |
| phenanthro-9',10':2,3-quinoxaline |
| dibenzo(a,c)phenazine |
| brn 0217169 |
| ai3-24100 |
| 1,2,3,4-dibenzphenazine |
| 1,2:3,4-dibenzophenazine |
| nsc 6945 |
| CBDIVE_001593 |
| dibenzo-(a,c)-phenazine |
| STK015716 |
| AKOS000629546 |
| phenanthro[9,10-b]chinoxalin |
| fa46h2q0ks , |
| 5-23-10-00183 (beilstein handbook reference) |
| unii-fa46h2q0ks |
| F0243-0007 |
| SCHEMBL732274 |
| KHPYJVQRBJJYSF-UHFFFAOYSA-N |
| dibenz[a,c]phenazine |
| DTXSID50175833 |
| Z56791881 |
| 1,2,3,4-dibenzophenazin |
| 15,22-diazapentacyclo[12.8.0.0?,?.0?,??.0??,??]docosa-1(14),2(7),3,5,8(13),9,11,15,17,19,21-undecaene |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.84
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.84 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.63 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |